• Aucun résultat trouvé

Development of a multiplex immunoassay

N/A
N/A
Protected

Academic year: 2021

Partager "Development of a multiplex immunoassay"

Copied!
25
0
0

Texte intégral

(1)

HAL Id: hal-01003256

https://hal.archives-ouvertes.fr/hal-01003256

Submitted on 6 Jun 2020

HAL is a multi-disciplinary open access archive for the deposit and dissemination of sci- entific research documents, whether they are pub- lished or not. The documents may come from teaching and research institutions in France or abroad, or from public or private research centers.

L’archive ouverte pluridisciplinaire HAL, est destinée au dépôt et à la diffusion de documents scientifiques de niveau recherche, publiés ou non, émanant des établissements d’enseignement et de recherche français ou étrangers, des laboratoires publics ou privés.

Development of a multiplex immunoassay

Sandra Blaise-Boisseau, Monique Guy, Emilye Leboucher, Elisa Dominguez, Annabelle Garnier, Anthony Relmy, Aude Allemandou., Margot Carocci,

Kamila Gorna, Aurore Romey, et al.

To cite this version:

Sandra Blaise-Boisseau, Monique Guy, Emilye Leboucher, Elisa Dominguez, Annabelle Garnier, et al..

Development of a multiplex immunoassay. Disconvac Meeting, Labo/service de l’auteur, Ville service, Pays service., Oct 2011, Bruxelles, Belgium. pp.24. �hal-01003256�

(2)

FMD-DISCONVAC

WP5: Improvement in FMD diagnostics Task 3:

Development of a multiplex immunoassay

S. Blaise-Boisseau, M.Guy, E. Leboucher, E. Dominguez, A. Garnier, A.

Relmy, A. Allemandou, M.Carocci, K. Gorna, A. Romey, S. Zientara, and L. Bakkali-Kassimi

(3)

Objectives

Development of a multiplex immunoassay for FMD diagnosis by using the Luminex liquid array technology

Simultaneous detection of antibodies against vesicular disease viruses and FMDV structural and non structural proteins

Serological discrimination between FMDV-infected and vaccinated animals in a single reaction

(4)

Microspheres (I)

Use of magnetic carboxylated beads

Ø 6,5 µm

each bead is impregnated with a unique infrared/ red dye ratio

(5)

Magplex carboxylated beads

Immobilization of 6–150 kDa proteins carbodiimide reaction (covalent)

5-10µg/ coupling reaction (1.25 x 106 beads) 2500 to 5000 beads/assay

automatic magnetic bead washes

!!!Restrictions on use:

The protein sample must be free of sodium azide,BSA, glycine, Tris or amine-containing additives and must be suspended in PBS, pH 7.4.

Microspheres (II)

(6)

Principles of the luminex technology

(7)

Capture molecule:

FMD SP : VP1 (of all serotypes)

FMD NSP: 3ABC, 3A, 3B,3D and peptide 2B

VSV SP SVDV SP

Analyte:

Serum samples

Reporter molecule:

Secondary anti-species antibody, biotin labeled.

+ Streptavidine-Phyco- Erythrine (S-PE)

Multiplex Immunoassay Principle (I)

(8)

+

Y

Serum samples

Secondary Ab (Biotin) + S-PE

Healthy animals Vaccinated animals Infected animals

Reporter fluorescence intensity

Bead fluorescence intensity Y YY

Y Y

+ Y Y YY Y Y

Y Y YY Y Y

Y

VP1 3ABC 2B 3B 3D

VP1 3ABC

2B 3B 3D

Antigen-coupled Beads

3ABC 2B 3B 3D

Y Y Y Y Y

VP1 VP1 3ABC 2B 3B 3D

Y Y

Y Y Y Y

Y

Y Y Y Y

Y

Y Y Y Y

Y Y Y Y Y Y

Y Y Y

Multiplex Immunoassay Principle (II)

(9)

ANTIGENS PRODUCTION

(10)

FMDV proteins expressed in E. Coli

Purification on Ni-NTA column

Dialysis and concentration

BB L W1 W2 E1 E2 E3 E4

36 22

Anti-His

64 50

A3 A4 A5 A6 A7 A8

3D

A3 A4 A5 A6 A7 A8

3D

Anti-His

A4 A5 A6 A7 A8

3ABC

64 50

A4 A5 A6 A7 A8

3ABC

Anti-His

Capsid protein: VP1-6His Non structural proteins:

3ABC-6His, 3D-6His

(11)

COUPLING CONDITIONS

(12)

Beads coupling : Two strategies

R R

VP1 3ABC 3D

Direct coupling:

Bead/FMDVprotein

Anti-His

VP1 3ABC 3D

Indirect coupling:

Bead/anti-His antibody

(13)

Indirect coupling : optimization of the Anti-His Ab quantity

Anti-His

VP1 3ABC 3D

Anti-His Ab (µg)

Anti-mouse biotinylated Ab (ng)

Anti-His Ab (µg)

Anti-mouse biotinylated

Ab (ng)

Best results obtained with:

2 µg Anti-His Ab

250-500 ng Biotinylated Ab

(14)

Indirect coupling : optimization of the elisa blocking solution

- Optimal elisa blocking solution (sb) formulation:

PBS (pH 7.2), Tween 20 (0.02%), milk (5%)

- Mfi for coupled beads = 10 x mfi uncoupled beads

Uncoupled beads Anti His (2µg) coupled beads

(15)

Serological assay -preliminary results –

(simplex)

(16)

Indirect coupling

Anti-His

3D (50ng)

Analytes: bovine sera samples 2500 beads/well (2 µg Anti-His Ab) Serum dilution: 1/50

Anti-cow biotin: 1/1000 S-PE: 1/100

Low mfi values

signal-to-noise ratio < 4

(17)

Indirect coupling

Anti-His

3D (50ng)

Best results with SPE from qiagen Effect of 3D quantity on mfi values

Analytes: bovine sera sample 3D+

0 20 40 60 80 100 120 140 160

sans protéine

50ng 100 ng 200 ng 500 ng 1000 ng

mFI S-PE Biorad

S-PE Qiagen

2500 beads/well (2 µg Anti-His Ab) 3D his tag protein: 50 to 1000 ng/well Serum dilution: 1/50

Anti-cow biotin: 1/1000

S-PE: 1/100 (Biorad or qiagen)

(18)

Direct coupling

2500 beads/well

10 or 20 µg protein (1.25.106 beads) Serum dilution: 1/50

Anti-cow biotin: 1/1000 S-PE: 1/100

3ABC

3D

signal-to-noise ratio < 4

(19)

Direct coupling (3D): streptavidine titration

2500 beads/well

20 µg protein (1.25.106 beads) Serum dilution: 1/50

Anti-His Ab: 1/1000

Biotinylated Anti-cow or anti-mouse : 1/1000 S-PE: 1/25 to 1/200

3D

Optimal SPE dilution: 1/100 Signal to noise ratio: 8

Y Y

Y Y Y S-PE

Anti-mouse (biotin)

AntiTagHis mAb

(20)

Direct coupling (3D): Biotinylated Ab titration

2500 beads/well

20 µg protein (1.25.106 beads) Serum dilution: 1/50

Anti-His Ab: 1/1000

Biotinylated anti-mouse : 1/100 to 1/1000 S-PE: 1/100

3D

Optimal Biotinylated anti- mouse : 1/200

Signal to noise ratio: 8 Y Y

Y Y Y S-PE

Anti-mouse (biotin)

Anti Tag His mAb

(21)

Direct coupling (3D): Biotinylated Ab titration

2500 beads/well

20 µg protein (1.25.106 beads) Serum dilution: 1/50

Anti-His Ab: 1/1000

Biotinylated Anti-cow : 1/100 to 1/1000 S-PE: 1/100

3D

Optimal SPE dilution: 1/100 Anti-cow biotin: 1/200

Signal-noise ratio: 10

Bovine serum 3D+

Bovine serum 3D-

Bovine serum naïve

Bovine serum 3D+

w/o Ac II Ac II

w/o bovine serum

mfi

(22)

Two strategies to develop magnetic serological multiplex assay:

Indirect coupling Direct coupling

Optimization of several critical parameters (simplex, 3D) Elisa blocking solution

quantity of Anti His Ab coupled SPE concentration

biotinylated secondary Ab concentration

Conclusions

(23)

PERSPECTIVES

Producing proteins of interest in E. coli

Developing/ optimizing simplex serological immunoassay for each antigen coupled beads set and then developing multiplex assays

Determining best conditions for storage of coupled beads FMD SP : VP1 (of all serotypes) in progress…

FMD NSP: 3ABC, 3A, 3B,3D and peptide 2B in progress…

VSV SP SVDV SP

(24)

Team « Biology of Picornaviruses »

« BioPic »

Labib Bakkali Kassimi

Sandra Blaise Boisseau

Kamila Gorna Anthony

Relmy

Margot Carocci

Aurore Romey

Aude Allemandou Elisa Dominguez Annabelle GARNIER Stéphan

Zientara

(25)

Thank you for your attention…

"The research leading to these results have received funding from the European Community's Seventh Framework Programme (FP7/2007-2013)

under grant agreement n°°°° 226556. "

Références

Documents relatifs

Actinobacillus pleuropneumoniae reference strains and field isolates used for evaluation of 288. the PCR

Here we describe the development of a chemiluminescent enzyme-linked immunosorbent assay (CL-ELISA) that employs luminol, horseradish peroxidase as labeling enzyme (Botchkareva

The diag- nostic cut-off of the flavivirus MIA technology was deter- mined by ROC analysis for all the antigens using well- characterised sera found positive or negative by ELISA,

Margot Carocci, Aurore Romey, Anthony Relmy, Kamila Gorna, Sandra Blaise-Boisseau, Stephan Zientara, Labib Bakkali.. To cite

 La valence des tensions identitaires de l’étudiant dépend de la dynamique identitaire et du parcours biographique de l’étudiant, dans le sens où elle est liée à

Numérote dans l’ordre chronologique les étapes de la vie

We firstly optimized conditions for antibody microarray (surface chemistry, antibody concentrations). Then using the best conditions, we quantified uPA concentration in

1 L1 / Uv+, sens de marche FERMÉ 1 Inverseur, contact de fin de course FERMÉ 2 L1 / Uv+, sens de marche OUVERT 2 Contact à fermeture Fin de course FERMÉ 3 N / Uv-, conducteur neutre